1 HALF OF RED Flashcards

1
Q

What is Polymyalgia rheumatica

A

common systemic inflammatory disease that is one of the most common indications for long-term steroids. It is characterised by myalgia and muscles stiffness with preponderance to the neck, shoulder and pelvic girdle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is affected by polymyalgia rheumatica

A

PMR is predominantly a disease of older adults and rarely presents before 50 years old. The peak prevalence is estimated between 70-80 years. Women are 2-3 times more likely to be affected than men.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aetiology of PMR

A

there appears to be a pro-inflammatory response with elevated levels of IL-6, an increase in certain T-cell subsets and subclinical arterial inflammation in some patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genetic and environmental factors for aetiology of PMR

A

Genetic: PMR, like GCA, has been associated with several human leucocyte antigen (HLA) alleles (e.g. HLA-DR4).

Environmental: the cyclical pattern of cases and peak incidence in winter months suggests an infectious trigger.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Predominant sites of inflammation for PMR

A

proximal articular and periarticular structures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology of PMR

A
  • predominant site of inflammation includes bursae and tendons. Bursae are fluid-filled sacs that counteract the friction associated with tendons.
  • Despite the site of inflammation, patients still present with generalised muscle stiffness and pain, particularly in the shoulder and pelvic girdles.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristic sites in the upper and lower extremities associated with PMR:

A

Shoulder girdle: subdeltoid/subacromial bursitis and biceps tenosynovitis.

Pelvic girdle: bursae around the greater trochanters and ischial processes. liopectineal and iliopsoas bursitis. Hamstring tendinitis and hip synovitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Symptoms of PMR

A
  • Bilateral shoulder and/or hip girdle pain
  • Stiffness and upper limb tenderness: particularly mornings
  • Systemic features: low-grade fever, fatigue, weight loss
  • Low mood
  • Peripheral symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Signs of PMR

A
  • Reduced range of movement: shoulder, cervical spine, and hips
  • Inability to abduct shoulders past 90º
  • Synovitis and swelling
    Motor exam:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GCA and PMR

A

10% of patients with PMR will develop GCA. Therefore, it is essential to assess for features of GCA including unilateral headache, visual changes, jaw claudication, temporal artery tenderness, scalp pain and constitutional symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnosis of PMR

A
  • Age: 50 years or older at disease onset
  • Typical symptoms: bilateral, symmetrical shoulder and/or hip girdle pain associated with stiffness
  • Duration: > 2 weeks and lasting > 45 minutes at a time
  • Elevated inflammatory markers (ESR/CRP): supportive, but diagnosis can be made if normal
  • Rapid resolution of symptoms with corticosteroids: patient-reported global improvement of 70% or more within a week
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atypical features

A

Younger age of onset
Significant weight loss
Night pain
Neurological findings
Absence of core symptoms
Normal, or markedly elevated, inflammatory markers
Chronic onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management of PMR

A

Start on oral prednisolone 15mg daily
After initiation - prednisolone should be reduced once symptoms are fully controlled - usually after a period of 3-4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Steroid - related complications

A

teroid-induced hyperglycaemia, mood changes, insomnia, gastrointestinal bleeding, immunosuppression, weight gain, cushingoid appearance, osteoporosis and adrenal cortex suppression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prognosis of PMR

A

Up to 45% of patients may not respond to steroids within the first 3-4 weeks of treatment and a more extended course of steroids may be needed.

Thankfully, there is no increased mortality associated with PMR, but relapse is common and patients may develop morbidity associated with side-effects from corticosteroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Pagets?

A

A chronic bone disorder that is characterised by focal areas of increased bone remodelling, resulting in overgrowth of poorly organised bone.

Also known as osteitis deformans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Epidemiology of Pagets

A
  • Typically affects older people (rare in under-40s)
  • Commoner in temperate climates and anglo-saxons
  • UK has highest prevalence in the world
18
Q

Aetiology of Pagets

A
  • Can be triggered by infections e.g. measles virus
  • Linked to genetic mutations e.g. SQSTM1
19
Q

RF for Pagets

A
  • Family history
  • Age >50 years
  • Infection
20
Q

Pathophysiology of Pagets

A
  • Phase 1 - lytic phase
    • Osteoclasts which have up to 100 nuclei aggressively demineralise the bone (x20 more than normal).
  • Phase 2 - mixed phase (lytic and blastic)
    • Blastic phase - rapid, disorganised proliferation of new bone tissue by a large number of osteoblasts. Collagen deposited in a haphazard way.
  • Phase 3 - sclerotic phase
    • New bone formation exceeds bone resorption. The bone is structurally disorganised and weak.
21
Q

clinical manifestations of Pagets

A
  • Pain
  • Hearing loss
  • VIsion loss
  • Kyphosis - curved spine
  • Pelvic asymmetry
  • Bowlegs
22
Q

Investigation for Pagets

A

Biochemisty - ALP elevated, calcium and phosphate normal
X- ray - bone enlargement and deformity,
Bone biopsy

23
Q

Management for Pagets

A
  • Pain relief
    • NSAIDs
  • Anti-resorptive medication - Biphosphonates e.g. alendronic acid
    • Along with calcium and vit D supplementation
  • Surgery -
    • Correct bone deformities
    • Decompress impinged nerve
    • Decrease fracture risk
24
Q

Monitoring Pagets

A

Check the serum alkaline phosphatase (ALP) and review symptoms. Effective treatment should normalise the ALP and eliminate symptoms.

25
Q

Complications for Pagets

A

Paget’s sarcoma (osteosarcoma)
Spinal stenosis and spinal cord compression
- Fractures
- Vision loss
- Hearing loss
- Arthritis - if any joint involvement

26
Q

Definition of osteomalacia

A

Osteomalacia is a metabolic bone disease characterised by incomplete mineralisation of the underlying mature organic bone matrix (osteoid) following growth plate closure in adults.

This results in softening of the bones.
Results in rickets in children and osteomalacia in adults

27
Q

Epidemiology of osteomalacia

A
  • In the developed world, it is estimated that 40% of individuals over the age of 50 years are vitamin D deficient; this is the most common cause of osteomalacia.
  • Fortification of foods with vitamin D and the use of vitamin supplements has greatly reduced the incidence of osteomalacia in the Western world.
28
Q

Aetiology of osteomalacia

A
  • Vitamin D
  • Calcium
  • Phosphate
29
Q

RFs for osteomalacia

A
  • Limited exposure to sunlight
  • Dark skin
  • Dietary vitamin D deficiency
  • CKD
  • Vit D resistance
  • Liver dysfunction
  • Malabsorption
  • Tumour induced
30
Q

Vit D activation

A

Vitamin D requires activation by the liver (25-hydroxylation) and then by the kidney (1-alpha-hydroxylation/ calcitriol). Active vitamin D raises serum calcium and phosphate by increasing intestinal absorption, as well as resorption from the bone and kidney. These electrolytes then contribute to bone mineralisation.

31
Q

What does parathyroid hormone do

A

Stimulates resorption of Ca2+ and phosphate from bone, increases Ca2+ reabsorbtion and phosphate excretion from kidneys and also boosts 1-alpha-hydroxylase activity causing increased levels of vit D.

32
Q

Pathophysiology of osteomalacia

A

Osteomalacia is primarily caused byvitamin D deficiencywhich can be due to reduced sunlight exposure, poor nutrition, malabsorption, liver failure, and renal failure. Occasionally osteomalacia can be caused by hypophosphataemia due to inborn errors in metabolism.

33
Q

Signs of osteomalacia

A
  • Skeletal deformities
  • Waddling gait: a late sign
  • Signs of hypocalcaemia: such as Chvostek sign
34
Q

Symptoms of osteomalacia

A
  • Generalised bone pain: rib, hip, pelvis, thigh and foot pain are typical
  • Proximal muscle weakness
  • Difficulty walking upstairs
  • Muscle spasms and numbness due to hypocalcaemia
  • Fracture: often secondary to mild trauma, most commonly affecting the long bones
35
Q

Primary investigation for osteomalacia

A
  • Serum calcium and phosphate
  • Serum 25-hydroxy vitamin D
  • pth LEVEL
  • Serum ALP
36
Q

GS investigation for osteomalacia

A

Iliac bone biopsy with double tetracycline labelling

37
Q

DD for osteomalacia

A
  • Osteoporosis
  • Paget’s disease
38
Q

tREATMENT OF OSTEOMALACIA

A

Treat underlying cause
Calcium D3 given if dietary insufficiency

39
Q

If there is malabsorption or hepatic disease what do you do?

A

Vitamin D2 (ergocalciferol) or IM calcitriol. If renal disease of vitamin D resistance, then give alfacalcidol or calcitriol

40
Q

Monitoring osteomalacia

A

Monitor plasma Ca2+, initially weekly, and nausea and vomiting.

41
Q

Consequences of osteomalacia

A
  • Insufficiency fracture
  • Complications of treatment:hypercalcaemia, hyperphosphataemia
  • Secondary hyperparathyroidism
42
Q

Prognosis of osteomalacia

A

The prognosis of patients with osteomalacia is generally very good but is dependent on the underlying cause.

Rickets and osteomalacia normally respond rapidly to vitamin D replacement, which manifests as increased mobility and muscle strength